AWAKENS, Inc. announced that it has received funding from 500 Startups, Japanese Organization for Medical Device Development, Inc., M3, Inc., and other investors
August 21, 2017
Share
AWAKENS, Inc. announced that it has received seed round of funding led by new investor 500 Startups Japan LP, a fund managed by 500 Startups on August 22, 2017. The transaction included participation from other new investors, Japanese Organization for Medical Device Development, Inc., M3, Inc., and several angel investors including Tomihisa Kamada, Tsunegoro Nishino, and Hiroaki Kitano.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
AWAKENS, Inc. announced that it has received funding from 500 Startups, Japanese Organization for Medical Device Development, Inc., M3, Inc., and other investors
M3, INC. 
